Display options
Cite
Ahmed AB, Latimer RD, Vuylsteke A. Cardiovascular pharmacology: new drugs and new indications. Curr Opin Anaesthesiol. 2000;13(1):5-13doi: 10.1097/00001503-200002000-00002.
Ahmed, A. B., Latimer, R. D., & Vuylsteke, A. (2000). Cardiovascular pharmacology: new drugs and new indications. Current opinion in anaesthesiology, 13(1), 5-13. https://doi.org/10.1097/00001503-200002000-00002
Ahmed, A B, et al. "Cardiovascular pharmacology: new drugs and new indications." Current opinion in anaesthesiology vol. 13,1 (2000): 5-13. doi: https://doi.org/10.1097/00001503-200002000-00002
Ahmed AB, Latimer RD, Vuylsteke A. Cardiovascular pharmacology: new drugs and new indications. Curr Opin Anaesthesiol. 2000 Feb;13(1):5-13. doi: 10.1097/00001503-200002000-00002. PMID: 17016273.
Copy Download .nbib Format: NLM
Share it on

Curr Opin Anaesthesiol. 2000 Feb;13(1):5-13. doi: 10.1097/00001503-200002000-00002.

Cardiovascular pharmacology: new drugs and new indications.

Current opinion in anaesthesiology

A B Ahmed, R D Latimer, A Vuylsteke

Affiliations

  1. Department of Anaesthesia, Papworth Hospital, Cambridge, UK.

PMID: 17016273 DOI: 10.1097/00001503-200002000-00002

Abstract

This review presents a brief overview of some of the many exciting developments that are taking place in the field of cardiovascular pharmacology. Research continues to progress at a rapid rate, and we can expect many drugs to enter the clinical arena within the next few years. It must be borne in mind, however, that the pharmaceutical industry and hospital budgetary restrictions sometimes limit drug development and occasionally interrupt clinical trials, even before their results have been obtained.

Publication Types